Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program
- PMID: 22622076
- PMCID: PMC3872063
- DOI: 10.1097/FTD.0b013e3182526e6a
Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program
Abstract
Objectives: To understand reasons for lost-to-follow-up (LTFU) from a community-based antiretroviral therapy program in Uganda.
Study design: Retrospective cohort of patients LTFU between May 31, 2001, to May 31, 2010, was examined. A representative sample of 579 patients traced to ascertain their outcomes.
Methods: Mixed methods were used. Using "stopped care" as the hazard and "self-transferred" as the comparator, we examined using Cox proportional multivariable model risk factors for stopping care.
Results: Overall, 2933 of 3954 (74.0%) patients were LTFU. Of 579 of 2933 (19%) patients sampled for tracing, 32 (5.5%) were untraceable, 66(11.4 %) were dead, and 481 (83.0%) found alive. Of those found alive, 232 (40.0%) stopped care, 249 (43.0%) self-transferred, whereas 61 (12.7%) returned to care at Reach Out Mbuya HIV/AIDS Initiative. In adjusted hazards ratios, born-again religion, originating from outside Kampala, resident in Kampala for <5 years but >1 year, having school-age children who were out of school, non-HIV disclosure, CD4 counts >250 cells per cubic millimeter and pre-antiretroviral therapy were associated with increased risk of stopping care. Qualitative interviews revealed return to a normal life as a key reason for LTFU. Of 61 patients who returned to care, their median CD4 count at LTFU was higher than on return into care (401/mm³ vs. 205/mm³, P < 0.0001).
Conclusions: Many patients become LTFU during the course of years, necessitating the need for effective mechanisms to identify those in need of close monitoring. Efforts should be made to improve referrals and mechanisms to track patients who transfer to different facilities. Additionally, tracing of patients who become LTFU is required to convince them to return.
Figures
Similar articles
-
Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.BMC Infect Dis. 2018 Oct 24;18(1):533. doi: 10.1186/s12879-018-3450-9. BMC Infect Dis. 2018. PMID: 30355356 Free PMC article.
-
Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.PLoS One. 2020 Apr 7;15(4):e0217606. doi: 10.1371/journal.pone.0217606. eCollection 2020. PLoS One. 2020. PMID: 32255796 Free PMC article.
-
High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.PLoS One. 2017 Sep 1;12(9):e0183823. doi: 10.1371/journal.pone.0183823. eCollection 2017. PLoS One. 2017. PMID: 28863160 Free PMC article.
-
The Causal Effect of Tracing by Peer Health Workers on Return to Clinic Among Patients Who Were Lost to Follow-up From Antiretroviral Therapy in Eastern Africa: A "Natural Experiment" Arising From Surveillance of Lost Patients.Clin Infect Dis. 2017 Jun 1;64(11):1547-1554. doi: 10.1093/cid/cix191. Clin Infect Dis. 2017. PMID: 28329184 Free PMC article.
-
Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis.Clin Infect Dis. 2018 Nov 13;67(11):1643-1652. doi: 10.1093/cid/ciy347. Clin Infect Dis. 2018. PMID: 29889240 Free PMC article.
Cited by
-
CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.J Epidemiol Community Health. 2016 Jun;70(6):549-55. doi: 10.1136/jech-2015-206629. Epub 2015 Dec 23. J Epidemiol Community Health. 2016. PMID: 26700300 Free PMC article.
-
Implementation and operational research: evaluating outcomes of patients lost to follow-up in a large comprehensive care treatment program in western Kenya.J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):e46-55. doi: 10.1097/QAI.0000000000000492. J Acquir Immune Defic Syndr. 2015. PMID: 25692336 Free PMC article.
-
The expansion of a patient tracer programme to identify and return patients loss to follow up at a large HIV clinic in Trinidad.AIDS Res Ther. 2021 Apr 23;18(1):20. doi: 10.1186/s12981-021-00341-3. AIDS Res Ther. 2021. PMID: 33892747 Free PMC article.
-
Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in Botswana.AIDS Care. 2020 Jun;32(6):722-728. doi: 10.1080/09540121.2019.1640843. Epub 2019 Jul 12. AIDS Care. 2020. PMID: 31298037 Free PMC article.
-
Lost to follow-up: failure to engage children in care in the first three months of diagnosis.AIDS Care. 2016 Nov;28(11):1402-10. doi: 10.1080/09540121.2016.1179714. Epub 2016 May 10. AIDS Care. 2016. PMID: 27160542 Free PMC article.
References
-
- Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366:378–384. - PubMed
-
- Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119–129. - PubMed
-
- Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18:887–895. - PubMed
-
- Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1 infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817–824. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials